Skip to main content

Structure Therapeutics Inc.

GPCR
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001888886

No open-market purchases or sales by Structure Therapeutics Inc. insiders were filed in the last 90 days; 192 institutions reported holding it in 13F filings for Q2 2026, worth $3.62B in total; no superinvestor holds it.

13F holders, Q2 2023

Institutional positions in Structure Therapeutics Inc. as of Jun 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
48
+10 vs. Q1 2023
Shares held
17.6M
+2.89M (+19.6%) vs. Q1 2023
Total value
$699.4M
+$353.2M (+102.0%) vs. Q1 2023
New holders
14
11 more added
Sold out
4
10 more reduced

Compare with Q1 2023: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting GPCR on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ2 2023: 48 institutions
Q1 2021: 0 institutionsQ2 2021: 0 institutionsQ3 2021: 0 institutionsQ4 2021: 0 institutionsQ1 2022: 0 institutionsQ2 2022: 0 institutionsQ3 2022: 0 institutionsQ4 2022: 0 institutionsQ1 2023: 38 institutionsQ2 2023: 48 institutionsQ3 2023: 84 institutionsQ4 2023: 122 institutionsQ1 2024: 119 institutionsQ2 2024: 168 institutionsQ3 2024: 164 institutionsQ4 2024: 167 institutionsQ1 2025: 154 institutionsQ2 2025: 174 institutionsQ3 2025: 159 institutionsQ4 2025: 200 institutionsQ1 2026: 199 institutionsQ2 2026: 192 institutions
Value heldQ2 2023: $699.4M
Q1 2021: $0Q2 2021: $0Q3 2021: $0Q4 2021: $0Q1 2022: $0Q2 2022: $0Q3 2022: $0Q4 2022: $0Q1 2023: $346.2MQ2 2023: $699.4MQ3 2023: $1.64BQ4 2023: $1.74BQ1 2024: $1.86BQ2 2024: $2.33BQ3 2024: $2.69BQ4 2024: $1.65BQ1 2025: $990.0MQ2 2025: $1.14BQ3 2025: $1.59BQ4 2025: $4.58BQ1 2026: $3.23BQ2 2026: $3.62B
Institutions holding GPCR and their total value by quarter
QuarterHoldersValue
Q2 2026192$3.62B
Q1 2026199$3.23B
Q4 2025200$4.58B
Q3 2025159$1.59B
Q2 2025174$1.14B
Q1 2025154$990.0M
Q4 2024167$1.65B
Q3 2024164$2.69B
Q2 2024168$2.33B
Q1 2024119$1.86B
Q4 2023122$1.74B
Q3 202384$1.64B
Q2 202348$699.4M
Q1 202338$346.2M
Q4 20220$0
Q3 20220$0
Q2 20220$0
Q1 20220$0
Q4 20210$0
Q3 20210$0
Q2 20210$0
Q1 20210$0

Institutions, Q2 2023

Shares, value and share of portfolio for each institution holding Structure Therapeutics Inc.; share changes are against Q1 2023.

Institutions holding GPCR in Q2 2023
InstitutionSharesValue% of portfolioChange in sharesAction
Deep Track Capital, LP2,646,782$110.0M5.14%00.0%Unchanged
Price T Rowe Associates Inc1,773,350$73.7M0.01%+986,845+125.5%Added
BVF Inc1,750,000$72.7M2.03%00.0%Unchanged
FMR LLC1,237,735$51.5M0.00%−11,691−0.9%Reduced
Driehaus Capital Management LLC1,135,936$47.2M0.60%+195,708+20.8%Added
Federated Hermes, Inc.1,014,700$42.2M0.10%−38,102−3.6%Reduced
Casdin Capital, LLC997,017$41.4M3.62%+320,000+47.3%Added
T. Rowe Price Investment Management, Inc.654,516$27.2M0.02%+56,408+9.4%Added
Deerfield Management Company, L.P. (Series C)627,813$26.1M0.56%+252,813+67.4%Added
Cormorant Asset Management, LP576,373$24.0M1.36%00.0%Unchanged
Monashee Investment Management LLC1,370,991$22.8M5.43%+1,200,991+706.5%Added
Point72 Asset Management, L.P.431,000$17.9M0.06%+81,138+23.2%Added
Logos Global Management LP400,000$16.6M2.30%+50,000+14.3%Added
Jennison Associates LLC399,780$16.6M0.01%00.0%Unchanged
BlackRock Inc.394,846$16.4M0.00%−5,154−1.3%Reduced
TCG Crossover Management, LLC350,000$14.5M2.39%00.0%Unchanged
Citadel Advisors LLC349,663$14.5M0.02%−16,624−4.5%Reduced
Franklin Resources Inc250,809$10.4M0.00%−74,191−22.8%Reduced
Wellington Management Group LLP210,269$8.74M0.00%+110,370+110.5%Added
Adage Capital Partners GP, L.L.C.192,398$8.00M0.02%−100,000−34.2%Reduced
Woodline Partners LP170,000$7.07M0.08%00.0%Unchanged
Janus Henderson Group PLC77,430$3.22M0.00%−268,991−77.6%Reduced
Octagon Capital Advisors LP75,000$3.12M0.44%−18,692−20.0%Reduced
TD Asset Management Inc72,709$3.02M0.00%+36,763+102.3%Added
Nantahala Capital Management, LLC50,000$2.08M0.25%00.0%Unchanged
ArrowMark Colorado Holdings LLC50,000$2.08M0.02%00.0%Unchanged
Millennium Management LLC44,226$1.84M0.00%+8,767+24.7%Added
Prudential Financial Inc42,000$1.75M0.00%00.0%Unchanged
Manufacturers Life Insurance Company, The40,631$1.69M0.00%+40,631New
Avidity Partners Management LP37,800$1.57M0.05%+37,800New
SVB Financial Group35,353$1.47M2.78%00.0%Unchanged
Renaissance Technologies LLC32,900$1.37M0.00%+32,900New
China Universal Asset Management Co., Ltd.27,267$1.13M0.35%+27,267New
Maven Securities LTD25,000$1.04M0.15%+25,000New
Lynx1 Capital Management LP23,000$956.1K0.63%00.0%Unchanged
Weiss Multi-Strategy Advisers LLC15,173$631.0K0.01%+15,173New
Platinum Investment Management Ltd15,000$623.5K0.02%00.0%Unchanged
State Street Corp11,460$476.4K0.00%+11,460New
Fred Alger Management, LLC10,512$437.0K0.00%+10,512New
Geode Capital Management, LLC10,257$426.4K0.00%+10,257New
UBS Oconnor LLC10,193$423.7K0.01%−11,857−53.8%Reduced
Virtus ETF Advisers LLC3,513$146.0K0.09%+3,513New
Bank of America Corp1,684$70.0K0.00%+1,684New
Barclays PLC1,132$47.1K0.00%+1,132New
Pinpoint Asset Management Ltd900$37.0K0.00%+900New
Signaturefd, LLC100$4.16K0.00%00.0%Unchanged
Tower Research Capital LLC (TRC)67$2.79K0.00%−33−33.0%Reduced
UBS Group AG2$830.00%+2New
Artal Group S.A.0$00.00%−75,000−100.0%Sold out
Point72 Middle East FZE0$00.00%−8,474−100.0%Sold out
Cubist Systematic Strategies, LLC0$00.00%−805−100.0%Sold out
Morgan Stanley0$00.00%−11−100.0%Sold out